PHOENIX--(BUSINESS WIRE)--A study co-authored by Arizona Oncology Services (AOS) reports “outstanding” early experiences with the SAVI™ applicator -- particularly for minimal side effects and the device’s potential to increase the number of women eligible for shorter breast cancer radiation treatment.
